UC Riverside will lead a multi-campus consortium tasked with researching the origins of COVID-19, which might ultimately lead to methods of stopping its propagation, it was announced Wednesday.
A new COVID-19 study is currently enrolling patients, and researchers believe it has the potential to change the course of the virus around the world. The study is examining the effects of Colchicine, a widely available and inexpensive anti-inflammatory drug on one of the most common, and most debilitating side effects of SARS-CoV-2–acute respiratory distress syndrome (ARDS).
The world has been living through the COVID-19 pandemic for nearly eight months. Much is still unknown about the illness that has stricken 14.8 million people and killed more than 610,000 worldwide, but every day brings new insights and developments. Columbia experts have been at the forefront of the international response to this crisis. We asked them to review what we’ve learned, so far, and to discuss the most significant challenges ahead.